Health

RedHill presents positive Phase 2 results for oral opaganib in patients with COVID-19 pneumonia – News-Medical.Net

RedHill Biopharma Ltd., a specialty biopharmaceutical company, today announced presentation of the positive Phase 2 safety and…

Published

4 years ago

June 22, 2021

Noosa Online News Publisher

RedHill Biopharma Ltd. (Nasdaq: RDHL) (“RedHill” or the “Company”), a specialty biopharmaceutical company, today announced presentation of the positive Phase 2 safety and efficacy data for oral opaganib (Yeliva®, ABC294640) in hospitalized patients with…

Click here to view the original article.

Related Topics:Australia News-Medical.Net

Up Next

Fat biomolecules are associated with various cancers, show studies – News-Medical.Net

Don't Miss

How science demolishes the right-wing fiction of a Wuhan “lab leak” as the source of coronavirus – WSWS

Noosa News24 hours ago

NRL live updates: Newcastle Knights vs Melbourne Storm, St George Illawarra Dragons vs Sydney Roosters, North Queensland Cowboys vs Canterbury Bulldogs